Opus Genetics, Stock Analysis
| IRD Stock | 1.26 0.11 9.57% |
Opus Genetics, is overvalued with Real Value of 1.05 and Hype Value of 1.26. The main objective of Opus Genetics, stock analysis is to determine its intrinsic value, which is an estimate of what Opus Genetics, is worth, separate from its market price. There are two main types of Opus Genetics,'s stock analysis: fundamental analysis and technical analysis.
The Opus Genetics, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Opus Genetics,'s ongoing operational relationships across important fundamental and technical indicators.
Opus |
Opus Stock Analysis Notes
About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Opus Genetics, recorded a loss per share of 1.09. The entity last dividend was issued on the 6th of November 2020. The firm had 1:4 split on the 6th of November 2020. To learn more about Opus Genetics, call MBA MD at 248 957 9024 or check out https://opusgtx.com.Opus Genetics, Quarterly Total Revenue |
|
Opus Genetics, Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Opus Genetics,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Opus Genetics, or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Opus Genetics, may become a speculative penny stock | |
| Opus Genetics, had very high historical volatility over the last 90 days | |
| Opus Genetics, was previously known as OCUP Old and was traded on NASDAQ Exchange under the symbol OCUP. | |
| The company reported the last year's revenue of 19.05 M. Reported Net Loss for the year was (9.99 M) with loss before taxes, overhead, and interest of (15.39 M). | |
| Opus Genetics, generates negative cash flow from operations | |
| About 16.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 |
Opus Largest EPS Surprises
Earnings surprises can significantly impact Opus Genetics,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-11 | 2024-09-30 | -0.25 | -0.2879 | -0.0379 | 15 | ||
2024-05-10 | 2024-03-31 | -0.1433 | -0.29 | -0.1467 | 102 | ||
2024-03-08 | 2023-12-31 | -0.05 | -0.21 | -0.16 | 320 |
Opus Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 35.67 M.Management Efficiency
Opus Genetics, has Return on Asset of (0.3895) % which means that on every $100 spent on assets, it lost $0.3895. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.643) %, meaning that it generated no profit with money invested by stockholders. Opus Genetics,'s management efficiency ratios could be used to measure how well Opus Genetics, manages its routine affairs as well as how well it operates its assets and liabilities. As of March 21, 2025, Total Assets is expected to decline to about 40.3 M. Non Current Assets Total is expected to grow at the current pace this yearThe strategic initiatives led by Opus Genetics,'s management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 21st of March, Opus Genetics, holds the Semi Deviation of 4.67, risk adjusted performance of 0.0217, and Coefficient Of Variation of 6645.64. Opus Genetics, technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Opus Genetics, information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Opus Genetics, is priced some-what accurately, providing market reflects its current price of 1.26 per share. Given that Opus Genetics, is a hitting penny stock territory we advise to closely look at its total risk alpha.Opus Genetics, Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Opus Genetics, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Opus Genetics,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Opus Genetics, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opus Genetics, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opus Genetics,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opus Genetics, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opus Genetics, Predictive Daily Indicators
Opus Genetics, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Opus Genetics, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Opus Genetics, Forecast Models
Opus Genetics,'s time-series forecasting models are one of many Opus Genetics,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opus Genetics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Opus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Opus Genetics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Opus Genetics,. By using and applying Opus Stock analysis, traders can create a robust methodology for identifying Opus entry and exit points for their positions.
Opus Genetics, is entity of United States. It is traded as Stock on NASDAQ exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Opus Genetics, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |